drugset / Trial / NCT00006209

A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

NCT00006209 ↗

Phase 1 Unknown 24 enrolled Aaron Diamond AIDS Research Center
Treatment

Summary

The purpose of this study is to see if it is safe to give tucaresol to HIV-infected patients who are taking combination anti-HIV therapy (HAART). This study also examines the effect tucaresol has on viral load (level of HIV in the body) when tucaresol is used with HAART.

Timeline

Start
2000-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Tucaresol Small molecule — —